Medication history

OTHER3 trials

Sponsors

First Affiliated Hospital Xi'an Jiaotong University, Hu Liangshuo

Conditions

COVID-19Hepatitis B VirusHepatocellular CarcinomaHepatocellular Carcinoma (HCC)Liver TransplantationOrgan TransplantationSurvivalSurvival Rate

Unknown Phase

Effects of Antiviral Therapy on Patients With HBV-related HCC

CompletedNCT05406089

First Affiliated Hospital Xi'an Jiaotong UniversityHepatitis B Virus, Hepatocellular Carcinoma, Survival

Start: 2016-01-01End: 2019-06-30Updated: 2022-06-21

Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation

CompletedNCT05685888

First Affiliated Hospital Xi'an Jiaotong UniversityCOVID-19, Organ Transplantation

Start: 2015-01-01End: 2023-01-05Updated: 2023-01-17

Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

CompletedNCT07418138

Hu LiangshuoHepatocellular Carcinoma (HCC), Liver Transplantation, Survival Rate +1

Start: 2015-01-01End: 2024-12-31Updated: 2026-02-18

Related Papers

Association of Pre-Transplant Tyrosine Kinase Inhibitor Therapy With Tumor Response and Survival in Hepatocellular Carcinoma: A 10-Year Retrospective Cohort Study of 427 Patients.

2026-07-09